← Holders
Sanofi
What Sanofi reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1121404 · Filed Nov 5, 2026
- Positions
- 16
- Reported value
- $629.9M
- Opened
- 6
- Closed
- 0
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$260.4M9 positions
- Dec 31, 2025$310.4M8 positions
- Mar 31, 2026$336M9 positions
- Jun 30, 2026$534M10 positions
- Sep 30, 2026$629.9M16 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
MGTXMeiraGTx Holdings plc | 12.2M | ±0% | $134.2M | 21.3% |
INBXInhibrx Biosciences, Inc. | 1.2M | ±0% | $115.9M | 18.4% |
NVAXNovavax Inc | 6.9M | ±0% | $74.4M | 11.8% |
KRSAKorsana Biosciences, Inc. | 2M | New | $63.8M | 10.1% |
ODTXOdyssey Therapeutics, Inc. | 2M | −0.1% | $44.2M | 7% |
ANABAnaptysbio, Inc | 821.9K | ±0% | $41.3M | 6.6% |
AGMBAgomAb Therapeutics NV | 2.8M | ±0% | $30.9M | 4.9% |
TRAXFirst Tracks Biotherapeutics, Inc. | 821.9K | ±0% | $29.1M | 4.6% |
ETRAElectra Therapeutics, Inc. | 2.5M | New | $27.7M | 4.4% |
ATTOAttovia Therapeutics, Inc. | 1.1M | New | $18.6M | 2.9% |
LTGOLatigo Biotherapeutics, Inc. | 672.8K | New | $11.2M | 1.8% |
IMRXImmuneering Corp | 2.7M | ±0% | $11.1M | 1.8% |
MPLTMapLight Therapeutics, Inc. | 912K | ±0% | $9.3M | 1.5% |
SCTXScribe Therapeutics, Inc. | 500K | New | $9.2M | 1.5% |
SABSSAB Biotherapeutics, Inc. | 2.2M | New | $7M | 1.1% |
QTTBQ32 Bio Inc. | 244.1K | ±0% | $2M | 0.3% |